This study tests a new HIV drug called fostemsavir in children and teens (ages 6 to 17) whose current HIV medicines are no longer working because the virus has become resistant. The drug is given along with other tailored HIV medicines. The goal is to see if it is safe and can lo…
Phase: PHASE1, PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC